MedPath

中山康方生物医药有限公司

Ownership
-
Established
2012-03-19
Employees
-
Market Cap
-
Website
www.akesobio.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Ebdarokimab Injection

Product Name
爱达罗
Approval Number
国药准字S20250017
Approval Date
Apr 15, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.